![[4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl-pivalate-1146629-77-7.jpg](https://ecdn6-nc.globalso.com/upload/p/2809/image_product/2024-12/4-1h-pyrazol-4-yl-7h-pyrrolo-2-3-d-pyrimidin-7-yl-methyl-pivalate-1146629-77-7.jpg)
![1146629-77-7-[4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl-pivalate.jpg](https://ecdn6-nc.globalso.com/upload/p/2809/image_product/2024-12/1146629-77-7-4-1h-pyrazol-4-yl-7h-pyrrolo-2-3-d-pyrimidin-7-yl-methyl-pivalate.jpg)
[4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate
Basic information
Product Name: [4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate
Synonyms:
CAS: 1146629-77-7
MF: C15H17N5O2
MW: 299.33
Chemical Properties
Boiling Point: 536.7±50.0 °C(Predicted)
Density: 1.33±0.1 g/cm3(Predicted)
storage temp: 2-8°C
Solubility: NA
Form: NA
Pka: 10.76±0.50(Predicted)
Color: NA
InChI: NA
InChIKey: NA
SMILES: NA
product description
The following is an introduction to the properties, uses, preparation methods and safety information of this compound:
Quality:
- Appearance: The compound is a white solid.
- Solubility: The compound has some solubility in common solvents.
Use:
1146629-77-7, also known as [4-(1H-pyrazole-4-yl)-7H-pyrrolo[2,3-D]pyrimidin-7-yl]methyl valerate, is a key pharmaceutical intermediate, mainly used in the synthesis of baricitinib.
Method: A common preparation method is to produce the compound by reacting 1H-pyrazole-4-amine and 7H-pyrrolo[2,3-D]pyrimidine-7-ol methyl tevalerate through the reaction of the compound.
Safety Information:
- Standard laboratory safety practices should be followed when handling and using the compound, and risks need to be assessed and managed on a case-by-case basis.